Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Chordia Therapeutics
company
About
Chordia Therapeutics is a research and development type bioventure specializing in oncology field.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥1.20B
- Industries
- Health Diagnostics,Medical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of cancer with high unmet medical need.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥1.20B
Chordia Therapeutics has raised a total of
¥1.20B
in funding over 2 rounds. Their latest funding was raised on
Nov 23, 2017 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 23, 2017 | Series A | ¥1.20B | 1 |
Takeda
|
— | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
